No legal services. No AB or US entity formation. No L-1, E-2, EB-5, or O-1 visa work. No US tax structuring, FATCA analysis, or Swedish-US double-taxation treaty review. No US banking introductions. No fiduciary services. No regulatory licensing, FDA submissions, ITAR or EAR export-control filings, or US securities work including S-1 drafting, F-1 drafting, or SEC filings. No IP filing. No contract drafting. No US recruiting or executive search. No M&A advisory. No IPO underwriting or banking placement.
These belong with Swedish counsel who specialise in US entry, with US counsel on the American side, with US securities counsel for US listings, with regulatory consultants who handle FDA and ITAR pathways, and with US investment banks for the IPO surface itself. The firm works inside the parameters they set. When a marketing decision carries legal, tax, regulatory, or securities-disclosure implications, the firm flags it and defers before execution.